Professor George Jelinek is Head of the Neuroepidemiology Unit (NEU) within the Melbourne School of Population and Global Health at the University of Melbourne.
The NEU’s charter is to investigate the modifiable lifestyle risk factors that predict the progression of MS with a view to refining a preventive medicine approach to management of the disease.
Dr Jonathan White gives his view on the three-year follow up results of the STOP-MS study which aims to investigate whether people with MS who attend lifestyle retreats, show improvement in symptoms after adapting their lifestyles.
A new research paper from the Neuroepidemiology Unit (NEU) at the University of Melbourne aimed to investigate whether people with MS who have attended a lifestyle retreat are leading healthier lives three years later.
Professor George Jelinek and the team at the NEU are competing in this year’s ‘Battle of the Labs’, and they need your vote!
A new NEU research paper examines the role and experience of partners of people with MS.
Substantial pain is a major problem for many with MS. Affecting between 30-85% of people with MS, it can be headache, back or musculoskeletal pain, neuropathic pain, or may accompany spasms or spasticity.
Ever wondered if there are differences between countries in how people with MS fare? At the Neuroepidemiology Unit (NEU) in the Melbourne School of Population and Global Health at the University of Melbourne, we were pondering this question.